CN Patent

CN120569186A — Glp-1激动剂的制剂、装置及使用方法

Assigned to Nano Precision Medical Co · Expires 2025-08-29 · 1y expired

What this patent protects

本公开提供了制剂、方法和可植入装置，通过长期(如1年或更长时间)释放所需治疗剂(如司美格鲁肽)来提高患者顺应性。司美格鲁肽的浓度(w/w)大于1％，例如约1.1％w/w至约35％w/w。

USPTO Abstract

本公开提供了制剂、方法和可植入装置，通过长期(如1年或更长时间)释放所需治疗剂(如司美格鲁肽)来提高患者顺应性。司美格鲁肽的浓度(w/w)大于1％，例如约1.1％w/w至约35％w/w。

Drugs covered by this patent

Patent Metadata

Patent number
CN120569186A
Jurisdiction
CN
Classification
—
Expires
2025-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Nano Precision Medical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.